Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready
Ingenious Ingredients LP is currently handling 5 pending office actions within the Biotechnology & Pharmaceuticals technology area. This volume of activity suggests a robust filing strategy, with multiple patent applications undergoing simultaneous review. The presence of 5 pending office actions indicates that the company is seeking to establish a significant presence in this specific sector.
The prosecution is notably decentralized, involving 5 distinct examiners and 5 distinct art units. This distribution across the 5 distinct examiners means that the company's technology is being evaluated from many different perspectives. While this increases the complexity of managing the portfolio, it also reduces the risk that a specific examiner's outlook will impact the entire set of Biotechnology & Pharmaceuticals filings.
GALSTER, SAMUEL LEONARD is the busiest examiner, currently assigned 1 busiest examiner pending action. Because GALSTER, SAMUEL LEONARD handles 1 busiest examiner pending action, the workload is spread among the various officials. Practitioners must maintain coordination to ensure that the arguments presented to the 5 distinct art units remain consistent and do not negatively impact the overall portfolio.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 1 (20%) |
| Double-patenting + other | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GALSTER, SAMUEL LEONARD | 1 | 50.9% | +43.2% |
| FOWLER, ALAN JEROME | 1 | 100.0% | +0.0% |
| WILSON, JERICA KATLYNN | 1 | 61.4% | +39.1% |
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 1 | 50.3% | +38.2% |
| HUTTER, GILLIAN A | 1 | 54.5% | +46.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17875207 | BIOACTIVE COMPOSITIONS AND METHODS OF USE THEREOF | FOWLER, ALAN JEROME | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17875368 | PARAXANTHINE-BASED CAFFEINE SUBSTITUTE COMPOSITIONS AND METHOD OF USE THEREOF IN SLOW CAFFEINE METABOLIZERS | WILSON, JERICA KATLYNN | 49d overdue |
| 17701349 | PARAXANTHINE-BASED COMPOSITIONS FOR PROMOTING WEIGHT LOSS | HUTTER, GILLIAN A | 18d overdue |
| 18070435 | PARAXANTHINE-BASED COMPOSITIONS FOR ENHANCING MUSCLE FUNCTION, NITRIC OXIDE SIGNALING, AND/OR MUSCLE GLYCOGEN LEVELS | GALSTER, SAMUEL LEONARD | 2d overdue |
| 17710787 | THE USE OF PARAXANTHINE TO IMPROVE PERFORMANCE IN VIDEO GAMERS | ABDALHAMEED, MANAHIL MIRGHANI ALI | — |
| Art Unit | Apps |
|---|---|
| 1693 | 1 |
| 1600 | 1 |
| 1621 | 1 |
| 1622 | 1 |
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18070435 | PARAXANTHINE-BASED COMPOSITIONS FOR ENHANCING MUSCLE FUNCTION, NITRIC OXIDE SIGNALING, AND/OR MUSCLE GLYCOGEN LEVELS | GALSTER, SAMUEL LEONARD | 1693 | §103DP | Non-Final OA | 2d overdue | Pending | Nov 28, 2022 |
| 17875207 | BIOACTIVE COMPOSITIONS AND METHODS OF USE THEREOF | FOWLER, ALAN JEROME | 1600 | §101§103§112 | Final Rejection | — | Pending | Jul 27, 2022 |
| 17875368 | PARAXANTHINE-BASED CAFFEINE SUBSTITUTE COMPOSITIONS AND METHOD OF USE THEREOF IN SLOW CAFFEINE METABOLIZERS | WILSON, JERICA KATLYNN | 1621 | §103 | Final Rejection | 49d overdue | Pending | Jul 27, 2022 |
| 17710787 | THE USE OF PARAXANTHINE TO IMPROVE PERFORMANCE IN VIDEO GAMERS | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §112DP | Non-Final OA | — | Pending | Mar 31, 2022 |
| 17701349 | PARAXANTHINE-BASED COMPOSITIONS FOR PROMOTING WEIGHT LOSS | HUTTER, GILLIAN A | 1625 | §103DP | Non-Final OA | 18d overdue | Pending | Mar 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial